You have 9 free searches left this month | for more free features.

Hedgehog Signaling Pathway

Showing 1 - 25 of 4,480

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Cancer Trial in Dallas (Itraconazole)

Active, not recruiting
  • Esophageal Cancer
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Obesity, Prediabetes Trial in La Jolla (Mirabegron)

Not yet recruiting
  • Obesity, Prediabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Not yet recruiting
  • Pyoderma Gangrenosum
  • +2 more
  • immunohistochemical methods
  • (no location specified)
Mar 21, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Biospecimen Collection
  • Follow-Up
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)

Recruiting
  • Basal Cell Carcinoma
  • Basal Cell Nevus Syndrome
  • ASN-002
  • Brisbane, Queensland, Australia
  • +5 more
Feb 10, 2022

Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Palo Alto, California
  • +5 more
Jan 12, 2023

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Carcinoma, Basal Cell Trial in United States (CX-4945)

Recruiting
  • Carcinoma, Basal Cell
  • Aurora, Colorado
  • +3 more
Mar 11, 2022

Carcinoma, Basal Cell Trial in Worldwide (cemiplimab)

Active, not recruiting
  • Carcinoma, Basal Cell
  • Phoenix, Arizona
  • +70 more
Jun 30, 2022

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

VEGF-B Signaling Pathway in Obesity and Metabolic Disease

Completed
  • Obesity
  • Metabolic Disease
    • Wuhan, Hubei, China
      Department of Endocrinology, Union Hospital,Tongji Medical Colle
    Apr 5, 2021

    Pontine Glioma Trial in Phoenix, Grand Rapids (Vismodegib)

    Terminated
    • Pontine Glioma
    • Phoenix, Arizona
    • +1 more
    Apr 20, 2022

    Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • La Jolla, California
    • +14 more
    Dec 29, 2021

    Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Santiago De Compostela, A Coruña, Spain
    • +5 more
    Dec 5, 2022

    Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)

    Recruiting
    • Basal Cell Carcinoma
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Mar 10, 2022

    Macrophages, GM-CSF and MARS Proteinosis

    Recruiting
    • Pulmonary Alveolar Proteinosis (PAP)
    • +2 more
    • Blood collection
    • Bronchoalveolar lavage fluid collection
    • Paris, France
      Hôpital Necker-Enfants Malades
    Jun 26, 2021

    NSCLC Trial in Dallas (Itraconazole)

    Completed
    • Non-small Cell Lung Cancer
    • Dallas, Texas
      UT Southwestern Medical Center
    Apr 7, 2021

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

    Not yet recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +3 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Sep 8, 2022

    Basal Cell Nevus Syndrome, Gorlin Syndrome Trial in Oakland, New York (GDC-0449)

    Completed
    • Basal Cell Nevus Syndrome
    • Gorlin Syndrome
    • Oakland, California
    • +1 more
    Dec 16, 2020

    Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)

    Completed
    • Metastatic Basal Cell Carcinoma
    • Locally Advanced Basal Cell Carcinoma
    • Treatment with vismodegib
    • Bordeaux, France
      Chu de Bordeaux
    Aug 17, 2022

    JAK/STAT Pathway in Sarcoidosis Granuloma Cells

    Recruiting
    • Sarcoidosis
    • JAK-STAT Pathway Deregulation
    • Blood sample
    • Bobigny, France
      Service de pneumologie Hôpital Avicenne
    Oct 3, 2022

    Solid Tumor, Adult, Hepatocellular Carcinoma Trial in Guangzhou (Combination of three inhibitors Trametinib, Everolimus and

    Recruiting
    • Solid Tumor, Adult
    • Hepatocellular Carcinoma
    • Combination of three inhibitors Trametinib, Everolimus and Lenvatinib
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Apr 7, 2021

    CNS Lymphoma Trial in Beijing (Zanubrutinib)

    Recruiting
    • CNS Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Aug 1, 2022